SWETHA SANNAREDDY: Open Payments
NPI 1104339910 · PLANO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 22 payments from 11 companies in 2025. Trend: 2023 $120 · 2024 $458 · 2025 $485
Food & beverage: $436Education: $49
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $176 |
| PFIZER INC. | 2 | $49 |
| Novo Nordisk Inc | 2 | $49 |
| Agios Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: JARDIANCE, Ozempic, PYRUKYND, FARXIGA, TZIELD, ELIQUIS, REXULTI, MOUNJARO.
Industry payments across IL — which companies pay providers there.
